Q16363 (LAMA4_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 123.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Laminin subunit alpha-4 Alternative name(s): Laminin-14 subunit alpha Laminin-8 subunit alpha Laminin-9 subunit alpha | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1823 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. |
| Subunit structure | Laminin is a complex glycoprotein, consisting of three different polypeptide chains (alpha, beta, gamma), which are bound to each other by disulfide bonds into a cross-shaped molecule comprising one long and three short arms with globules at each end. Alpha-4 is a subunit of laminin-8 (laminin-411), laminin-9 (laminin-421) and laminin-14 (laminin-423). |
| Subcellular location | Secreted › extracellular space › extracellular matrix › basement membrane. Note: Major component. |
| Tissue specificity | In adult, strong expression in heart, lung, ovary small and large intestines, placenta, liver; weak or no expression in skeletal muscle, kidney, pancreas, testis, prostate, brain. High expression in fetal lung and kidney. Expression in fetal and newborn tissues is observed in certain mesenchymal cells in tissues such as smooth muscle and dermis. |
| Domain | The alpha-helical domains I and II are thought to interact with other laminin chains to form a coiled coil structure. Domain G is globular. |
| Sequence similarities | Contains 4 laminin EGF-like domains. Contains 5 laminin G-like domains. |
| Caution | Gene LAMA4 was formerly called LAMA3. |
| Sequence caution | The sequence BAE06109.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Cell adhesion |
| Cellular component | Basement membrane Extracellular matrix Secreted |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Coiled coil Laminin EGF-like domain Repeat Signal |
| PTM | Disulfide bond Glycoprotein Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | cell adhesion Inferred from electronic annotation. Source: UniProtKB-KW regulation of cell adhesionInferred from electronic annotation. Source: InterPro regulation of cell migrationInferred from electronic annotation. Source: InterPro regulation of embryonic developmentInferred from electronic annotation. Source: InterPro |
| Cellular component | laminin-1 complex Inferred from electronic annotation. Source: InterPro |
| Molecular function | extracellular matrix structural constituent Traceable author statement. Source: ProtInc receptor bindingInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q16363-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q16363-2) The sequence of this isoform differs from the canonical sequence as follows: 266-272: Missing. | ||||||
| Isoform 3 (identifier: Q16363-3) The sequence of this isoform differs from the canonical sequence as follows: 66-120: KCNAGFFHTL...EKCLDGYIGD → VQCPCHCHPA...RKLEIKSFPL 121-1823: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 24 | 24 | Potential | ||||||||
| Chain | 25 – 1823 | 1799 | Laminin subunit alpha-4 | PRO_0000017060 | |||||||
Regions | |||||||||||
| Domain | 82 – 131 | 50 | Laminin EGF-like 1 | ||||||||
| Domain | 132 – 186 | 55 | Laminin EGF-like 2 | ||||||||
| Domain | 187 – 240 | 54 | Laminin EGF-like 3 | ||||||||
| Domain | 241 – 255 | 15 | Laminin EGF-like 4; truncated | ||||||||
| Domain | 833 – 1035 | 203 | Laminin G-like 1 | ||||||||
| Domain | 1047 – 1227 | 181 | Laminin G-like 2 | ||||||||
| Domain | 1234 – 1402 | 169 | Laminin G-like 3 | ||||||||
| Domain | 1469 – 1640 | 172 | Laminin G-like 4 | ||||||||
| Domain | 1647 – 1820 | 174 | Laminin G-like 5 | ||||||||
| Region | 256 – 832 | 577 | Domain II and I | ||||||||
| Coiled coil | 320 – 403 | 84 | Potential | ||||||||
| Coiled coil | 473 – 528 | 56 | Potential | ||||||||
| Coiled coil | 581 – 614 | 34 | Potential | ||||||||
| Coiled coil | 662 – 724 | 63 | Potential | ||||||||
| Coiled coil | 777 – 806 | 30 | Potential | ||||||||
| Motif | 724 – 726 | 3 | Cell attachment site Potential | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 1593 | 1 | Phosphotyrosine Ref.9 | ||||||||
| Glycosylation | 104 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 215 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 315 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 465 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 531 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 557 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||
| Glycosylation | 578 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||
| Glycosylation | 581 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||
| Glycosylation | 638 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 646 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 742 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||
| Glycosylation | 758 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 761 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 787 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||
| Glycosylation | 810 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||
| Glycosylation | 1093 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1288 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1366 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1418 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 82 ↔ 91 | By similarity | |||||||||
| Disulfide bond | 84 ↔ 98 | By similarity | |||||||||
| Disulfide bond | 101 ↔ 110 | By similarity | |||||||||
| Disulfide bond | 113 ↔ 129 | By similarity | |||||||||
| Disulfide bond | 132 ↔ 146 | By similarity | |||||||||
| Disulfide bond | 134 ↔ 155 | By similarity | |||||||||
| Disulfide bond | 157 ↔ 166 | By similarity | |||||||||
| Disulfide bond | 169 ↔ 184 | By similarity | |||||||||
| Disulfide bond | 187 ↔ 202 | By similarity | |||||||||
| Disulfide bond | 189 ↔ 209 | By similarity | |||||||||
| Disulfide bond | 212 ↔ 221 | By similarity | |||||||||
| Disulfide bond | 224 ↔ 238 | By similarity | |||||||||
| Disulfide bond | 273 | Interchain Probable | |||||||||
| Disulfide bond | 276 | Interchain Probable | |||||||||
| Disulfide bond | 1005 ↔ 1035 | By similarity | |||||||||
| Disulfide bond | 1201 ↔ 1227 | By similarity | |||||||||
| Disulfide bond | 1370 ↔ 1402 | By similarity | |||||||||
| Disulfide bond | 1617 ↔ 1640 | By similarity | |||||||||
| Disulfide bond | 1792 ↔ 1820 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 66 – 120 | 55 | KCNAG…GYIGD → VQCPCHCHPAGAPAPPRAVP HSSFSLSPPLSSPQCLESFT WARSVRKLEIKSFPL in isoform 3. | VSP_038853 | |||||||
| Alternative sequence | 121 – 1823 | 1703 | Missing in isoform 3. | VSP_038854 | |||||||
| Alternative sequence | 266 – 272 | 7 | Missing in isoform 2. | VSP_017542 | |||||||
| Natural variant | 94 | 1 | G → S. Corresponds to variant rs35349917 [ dbSNP | Ensembl ]. | VAR_056140 | |||||||
| Natural variant | 154 | 1 | R → W. Corresponds to variant rs11757455 [ dbSNP | Ensembl ]. | VAR_056141 | |||||||
| Natural variant | 283 | 1 | A → E. Corresponds to variant rs9400522 [ dbSNP | Ensembl ]. | VAR_061348 | |||||||
| Natural variant | 492 | 1 | L → H. Corresponds to variant rs3752579 [ dbSNP | Ensembl ]. | VAR_056142 | |||||||
| Natural variant | 498 | 1 | Y → H. Ref.2 Ref.8 Corresponds to variant rs1050348 [ dbSNP | Ensembl ]. | VAR_025550 | |||||||
| Natural variant | 1117 | 1 | G → S. Ref.1 Ref.2 Ref.8 Corresponds to variant rs2032567 [ dbSNP | Ensembl ]. | VAR_025551 | |||||||
| Natural variant | 1119 | 1 | P → R. Ref.1 Ref.2 Ref.8 Corresponds to variant rs1050349 [ dbSNP | Ensembl ]. | VAR_025552 | |||||||
| Natural variant | 1549 | 1 | N → S. Ref.2 Corresponds to variant rs12110554 [ dbSNP | Ensembl ]. | VAR_056143 | |||||||
| Natural variant | 1815 | 1 | V → I. Corresponds to variant rs3734292 [ dbSNP | Ensembl ]. | VAR_056144 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 143 | 1 | A → P in AAB34635. Ref.1 | ||||||||
| Sequence conflict | 178 | 1 | L → F in AAB34635. Ref.1 | ||||||||
| Sequence conflict | 283 | 1 | A → D in AAB34635. Ref.1 | ||||||||
| Sequence conflict | 283 | 1 | A → D in CAA62596. Ref.2 | ||||||||
| Sequence conflict | 283 | 1 | A → D in BAE06109. Ref.3 | ||||||||
| Sequence conflict | 283 | 1 | A → D in CAA54258. Ref.8 | ||||||||
| Sequence conflict | 1064 | 1 | T → P in AAB34635. Ref.1 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Primary structure and expression of a novel human laminin alpha 4 chain." Iivanainen A., Sainio K., Sariola H., Tryggvason K. FEBS Lett. 365:183-188(1995) [PubMed: 7781776] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANTS SER-1117 AND ARG-1119. Tissue: Fetal lung. |
| [2] | "The complete cDNA sequence of laminin alpha 4 and its relationship to the other human laminin alpha chains." Richards A.J., Al-Imara L., Pope F.M. Eur. J. Biochem. 238:813-821(1996) [PubMed: 8706685] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANTS HIS-498; SER-1117; ARG-1119 AND SER-1549. |
| [3] | "Preparation of a set of expression-ready clones of mammalian long cDNAs encoding large proteins by the ORF trap cloning method." Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M., Ohara R., Okazaki N., Koga H., Nagase T., Ohara O. Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain. |
| [4] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). |
| [5] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed: 14574404] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Pancreas. |
| [7] | "The structural organisation of LAMA4, the gene encoding laminin alpha4." Richards A.J., Luccarini C., Pope F.M. Eur. J. Biochem. 248:15-23(1997) [PubMed: 9310354] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-24. Tissue: Heart. |
| [8] | "Localization of the gene (LAMA4) to chromosome 6q21 and isolation of a partial cDNA encoding a variant laminin A chain." Richards A.J., Al-Imara L., Carter N.P., Lloyd J.C., Leversha M.A., Pope F.M. Genomics 22:237-239(1994) [PubMed: 7959779] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 236-1823 (ISOFORM 2), VARIANTS HIS-498; SER-1117 AND ARG-1119. Tissue: Heart. |
| [9] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1593, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed: 19159218] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-557; ASN-578; ASN-581; ASN-742; ASN-787 AND ASN-810, MASS SPECTROMETRY. Tissue: Liver. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | S78569 mRNA. Translation: AAB34635.1. X91171 mRNA. Translation: CAA62596.1. X70904 mRNA. Translation: CAA50261.1. AB210027 mRNA. Translation: BAE06109.1. Different initiation. BT006690 mRNA. Translation: AAP35336.1. Z99289, AL590106 Genomic DNA. Translation: CAI42325.1. AL590106 Genomic DNA. Translation: CAI12948.1. AL590106 Genomic DNA. Translation: CAI12949.1. AL590106, Z99289 Genomic DNA. Translation: CAI12950.1. BC004241 mRNA. Translation: AAH04241.1. Y14240 Genomic DNA. Translation: CAA74636.1. X76939 mRNA. Translation: CAA54258.1. |
| IPI | IPI00024406. IPI00329482. IPI00735310. |
| PIR | S68960. |
| RefSeq | NP_001098676.1. NM_001105206.1. NP_001098677.1. NM_001105207.1. NP_001098678.1. NM_001105208.1. NP_001098679.1. NM_001105209.1. NP_002281.2. NM_002290.3. |
| UniGene | Hs.654572. |
3D structure databases | |
| ProteinModelPortal | Q16363. |
| SMR | Q16363. Positions 33-285, 835-1020, 1235-1389, 1455-1822. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q16363. 15 interactions. |
| MINT | MINT-1200879. |
| STRING | Q16363. |
PTM databases | |
| PhosphoSite | Q16363. |
Polymorphism databases | |
| DMDM | 292495093. |
Proteomic databases | |
| PRIDE | Q16363. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000230538; ENSP00000230538; ENSG00000112769. |
| GeneID | 3910. |
| KEGG | hsa:3910. |
| UCSC | uc003pvt.2. human. uc003pvu.2. human. |
Organism-specific databases | |
| CTD | 3910. |
| GeneCards | GC06M112475. |
| HGNC | HGNC:6484. LAMA4. |
| HPA | HPA015693. |
| MIM | 600133. gene. |
| neXtProt | NX_Q16363. |
| PharmGKB | PA30273. |
| GenAtlas | Search... |
Phylogenomic databases | |
| GeneTree | ENSGT00600000084051. |
| HOVERGEN | HBG052299. |
| InParanoid | Q16363. |
| OMA | NHVVGPL. |
| OrthoDB | EOG4QFWCB. |
| PhylomeDB | Q16363. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | a6b1_a6b4_integrin_pathway. a6b1 and a6b4 Integrin signaling. amb2_neutrophils_pathway. amb2 Integrin signaling. foxm1pathway. FOXM1 transcription factor network. |
Gene expression databases | |
| ArrayExpress | Q16363. |
| Bgee | Q16363. |
| CleanEx | HS_LAMA4. |
| Genevestigator | Q16363. |
| GermOnline | ENSG00000112769. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR008985. ConA-like_lec_gl. IPR013320. ConA-like_subgrp. IPR002049. EGF_laminin. IPR001791. Laminin_G. IPR012680. Laminin_G_2. IPR009254. Laminin_I. IPR010307. Laminin_II. [Graphical view] |
| Gene3D | G3DSA:2.60.120.200. ConA_like_subgrp. 5 hits. |
| KO | K06241. |
| Pfam | PF00053. Laminin_EGF. 3 hits. PF02210. Laminin_G_2. 5 hits. PF06008. Laminin_I. 1 hit. PF06009. Laminin_II. 1 hit. [Graphical view] |
| SMART | SM00180. EGF_Lam. 3 hits. SM00282. LamG. 5 hits. [Graphical view] |
| SUPFAM | SSF49899. ConA_like_lec_gl. 5 hits. |
| PROSITE | PS00022. EGF_1. 1 hit. PS01248. EGF_LAM_1. 3 hits. PS50027. EGF_LAM_2. 3 hits. PS50025. LAM_G_DOMAIN. 5 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 15351. |
| SOURCE | Search... |
Entry information
| Entry name | LAMA4_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q16363 Secondary accession number(s): Q14731 Q9UJN9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with